The Valley Desk

NCT03368729 · Interventional trial

Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions HER2 Positive Breast Carcinoma, Metastatic Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov